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Humans have used yeasts for the production of food
and beverages since ancient times. Currently, Saccha-
romyces cerevisiae is also a key platform for the pro-
duction of molecules with biopharmaceutical and
industrial relevance. Yeasts are excellent choices as
cell factories for recombinant proteins due to several
reasons, including: (i) rapid growth, (ii) easy genetic
manipulation, (iii) complete genome sequences usually
available, plus (iv) their eukayotic machinery for post-
transcriptional and post-translational modiﬁcations. But
yeasts are much more than S. cerevisiae. The ‘other’
yeasts, so-called ‘non-conventional yeasts’, include a
wide spectrum of species, barely exploited, with multiple
peculiar physiological and molecular characteristics.
Lately, methylotrophic yeast Pichia pastoris (a.k.a
Komagataella phafﬁ or K. pastori) stands out as the
ideal host for heterologous expression, basically due to
three properties: its capacity to grow until very high
densities, its ability to secrete fully proper folded and
functional proteins, and its AOX1 (Alcohol oxidase I)
promoter, that is both strongly repressed in the pres-
ence of glucose, glycerol or ethanol, and fully induced
by methanol (Ahmad et al., 2014; Looser et al., 2015;
Yang et al., 2018). Nevertheless, using non-conven-
tional yeasts for biotechnological applications usually
clashes with a main bottleneck, as the process for clon-
ing the desired genes in not an easy and direct proce-
dure but sometimes a long and winding road.
Furthermore, in the last years a large amount of data
about previously unknown genes or proteins has been
generated by the ‘omics’ techniques. A signiﬁcant step
to study the biological functions of these proteins is its
puriﬁcation what needs a suitable system for their
heterologous expression. This hindrance has been
addressed in a recent report for Microbial Biotechnology
where Gonzalez and coworkers describe a tool that
allows the high-throughput expression of proteins in
S. cerevisiae and P. pastoris. in a simple and fast way.
The protocol involves the expression of heterologous
proteins by transformation of S. cerevisiae with a PCR
product that carries the gene of interest, obtained from
the original cDNA, and its integration either into the
S. cerevisiae genome or in an autonomous replicative
plasmid (pYEDIS) that contains the P. pastoris AOX1
promoter. In the last procedure, a cloning step can be
avoided as the genetic engineered plasmid is generated
by homologous recombination between two fragments
that are co-transformed into the yeast cell: one with the
PCR product, and the other with a linearized vector con-
taining different elements that drive expression and
secretion of the recombinant protein. This plasmid can
then be isolated from S. cerevisiae and directly used to
transform P. pastoris to express the target proteins, as
pYEDIS vector includes the elements necessary for
expression in P. pastoris. Also, this tool could be used
for other applications as expression of intracellular pro-
tein or chimeric proteins, only requiring PCR reactions
with the corresponding primers, and a one step transfor-
mation in S. cerevisiae. However, to take full advantage
of these cell factories, other limitations constraining pro-
duct yields need to be addressed. Further major restric-
tions are related to the differences in post-translational
modiﬁcations between yeasts and other eukaryotes, and
in the extra effort required for the production of a high
amount of protein products. These processes encom-
pass multiple steps and thousands of genes but their
imbalance usually leads to the induction of the unfolded
protein response and to protein degradation which
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deeply affects the system efﬁciency (de Ruijter et al.,
2016a,b). Several strategies are currently being used to
overcome protein folding limitations. In P. pastoris, over-
expressing genes involved in protein folding have been
partially successful, both with exogenous (Escherichia
coli gro chaperones) or endogenous genes (PDI1, ERO1
and GPX1) (Ben Azoun et al., 2016; Summpunn et al.,
2018). Furthermore, in S. cerevisiae, IgGs secretion
yields have been additionally improved when the overex-
pression of those genes was combined with an incre-
ment in the endoplasmic reticulum size (de Ruijter et al.,
2016a,b).
General shortcomings related to the industrial produc-
tion steps also need to be considered, including multi-tol-
erance towards high temperature, extreme pH, shearing
forces, ethanol or inhibitory compounds found in alter-
native cheaper carbon sources. Two non-excluding
approaches can be followed: the evaluation of ‘environ-
mental’ isolates, or the targeted modiﬁcation of laboratory
strains. Both ways are being used for the improvement of
heterologous cellulase secretion in S. cerevisiae: several
environmental-isolated strains have been evaluated iden-
tifying excellent candidates for industrial purposes (Davi-
son et al., 2016), and also a laboratory strain has been
modiﬁed with an engineered improved vesicle trafﬁcking
mechanism (Tang et al., 2017). Besides, AOX1 promoter
is commonly used in P. pastoris constructions but has
also its limitations. Methanol is highly ﬂammable so its
use as an effector for the promoter is not convenient in
large industrial facilities. This restriction can be overcome
either by using other promoters (GAP, TEF, PGK, ADH1,
ENO1, etc.) or by modifying AOX1 (changing its tran-
scription factors binding sites, dA:dT tracts, etc.), and
both strategies are also currently under investigation
(Ahmad et al., 2014; Yang et al., 2018).
We must not lose sight that other ‘less known’ yeasts
could also be good candidates as hosts for heterologous
secretory expression as thermotolerant Kluyveromyces
marxianus (Gombert et al., 2016) or halotolerant Debary-
omyces hansenii (Prista et al., 2016), although they face
similar problems as the ones described above.
Finally, some of the existing editing problems could be
addressed by a synthetic biology approach using new
tools as the CRISP/Cas9 system or novel projects as de
novo synthesizing yeast chromosomes. Nevertheless,
there is still a long road ahead as new genetic construc-
tions of non-conventional yeast strains for biotechnologi-
cal applications are still far from achieving the maturity
of S. cerevisiae systems. Only an integrating approach
from multiple perspectives will allow the achievement of
top yields in the production of secretory proteins for a




Ahmad, M., Hirz, M., Pichler, H., and Schwab, H.
(2014) Protein expression in Pichia pastoris: recent
achievements and perspectives for heterologous pro-
tein production. Appl Microbiol Biotechnol 98: 5301–
5317.
Ben Azoun, S., Belhaj, A.E., Gongrich, R., Gasser, B., and
Kallel, H. (2016) Molecular optimization of rabies virus
glycoprotein expression in Pichia pastoris. Microb
Biotechnol 9: 355–368.
Davison, S.A., den Haan, R., and van Zyl, W.H. (2016)
Heterologous expression of cellulase genes in natural
Saccharomyces cerevisiae strains. Appl Microbiol
Biotechnol 100: 8241–8254.
de Ruijter, J.C., Jurgens, G. and Frey, A.D. (2016a) Screen-
ing for novel genes of Saccharomyces cerevisiae involved
in recombinant antibody production. FEMS Yeast Res 17,
fow104.
de Ruijter, J.C., Koskela, E.V., and Frey, A.D. (2016b)
Enhancing antibody folding and secretion by tailoring the
Saccharomyces cerevisiae endoplasmic reticulum. Microb
Cell Fact 15: 87.
Gombert, A.K., Madeira, J.V. Jr, Cerdan, M.E., and Gonza-
lez-Siso, M.I. (2016) Kluyveromyces marxianus as a host
for heterologous protein synthesis. Appl Microbiol Biotech-
nol 100: 6193–6208.
Looser, V., Bruhlmann, B., Bumbak, F., Stenger, C., Costa,
M., Camattari, A., et al. (2015) Cultivation strategies to
enhance productivity of Pichia pastoris: a review. Biotech-
nol Adv 33: 1177–1193.
Prista, C., Michan, C., Miranda, I.M., and Ramos, J. (2016)
The halotolerant Debaryomyces hansenii, the Cinderella
of non-conventional yeasts. Yeast (Chichester, England)
33: 523–533.
Summpunn, P., Jomrit, J., and Panbangred, W. (2018)
Improvement of extracellular bacterial protein production
in Pichia pastoris by co-expression of endoplasmic reticu-
lum residing GroEL-GroES. J Biosci Bioeng 125: 268–
274.
Tang, H., Song, M., He, Y., Wang, J., Wang, S., Shen, Y.,
et al. (2017) Engineering vesicle trafﬁcking improves the
extracellular activity and surface display efﬁciency of cel-
lulases in Saccharomyces cerevisiae. Biotechnol Biofuels
10: 53.
Yang, J., Cai, H., Liu, J., Zeng, M., Chen, J., Cheng, Q.,
and Zhang, L. (2018) Controlling AOX1 promoter strength
in Pichia pastoris by manipulating poly (dA:dT) tracts. Sci
Rep 8: 1401.
ª 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
2 M. J. Huertas and C. Michan
